scholarly journals 2020 ESC Guidelines on Sports Cardiology and Exercise in Patients with Cardiovascular Disease

2020 ◽  
pp. 23-25
Author(s):  
Anaya Malik

ADVISING individuals with diseases of the heart on what types and intensities of sport to participate in is not a practice cardiologists typically have official guidelines on. A taskforce from ESC has now come together and created guidelines, the first of their kind, on exercise and sports participation in patients with cardiovascular disease. The guidelines were presented at the ESC Congress 2020 in a session chaired by Prof Antonio Pelliccia, Scientific Director of the Institute of Sports Medicine & Science from Rome, Italy. Pelliccia was joined by Prof Martin Halle, President of the European Association of Preventive Cardiology (EAPC), Munich, Germany, and Prof Matthias Wilhem, Head of the Centre for Preventive Cardiology, Sports Medicine, Department of Cardiology at the Inselspital, University Hospital of Bern, Switzerland. The guidelines derived from the need to assist patients who had experienced cardiovascular events and were questioning their limits of sports participation. Prof Halle commented on his experience in the taskforce: “The level of evidence is rather low, so it is very much the personal perspective and the experience of the experts which made us come to that one conclusion in the guidelines. It is something that should be developed in years to come.” A series of videos were shown, presented by specialists who were invited to discuss some of the most relevant topics of the guidelines.

2021 ◽  
Vol 26 (5) ◽  
pp. 4488
Author(s):  
Antonio Pelliccia ◽  
Sanjay Sharma ◽  
Sabiha Gati ◽  
Maria Bäck ◽  
Mats Börjesson ◽  
...  

The Task Force on sports cardiology and exercise in patients with cardiovascular disease of the European Society of Cardiology (ESC)


2021 ◽  
Vol 74 (6) ◽  
pp. 545
Author(s):  
Antonio Pelliccia ◽  
Sanjay Sharma ◽  
Sabiha Gati ◽  
Maria Bäck ◽  
Mats Börjesson ◽  
...  

2019 ◽  
Vol 27 (7) ◽  
pp. 770-776 ◽  
Author(s):  
Mats Borjesson ◽  
Mikael Dellborg ◽  
Josef Niebauer ◽  
Andre LaGerche ◽  
Christian Schmied ◽  
...  

This paper presents a brief summary of the recommendations from the Sports Cardiology section of the European Association of Preventive Cardiology (EAPC) on sports-participation in patients with coronary artery disease, coronary artery anomalies or spontaneous dissection of the coronary arteries, all entities being associated with myocardial ischaemia.1 Given the wealth of evidence supporting the benefits of exercise for primary and secondary prevention of coronary artery disease, individuals should be restricted from competitive sport only when a substantial risk of adverse event or disease progression is present. These recommendations aim to encourage regular physical activity including participation in sports and, with reasonable precaution, ensure a high level of safety for all individuals with coronary artery disease. The present document is based on available current evidence, but in most instances because of lack of evidence, also on clinical experience and expert opinion.


Author(s):  
Araceli Boraita ◽  
Carmen Adamuz ◽  
María Alcocer Ayuga ◽  
Amelia Carro ◽  
Leonel Díaz González ◽  
...  

Author(s):  
Antonio Pelliccia ◽  
Sanjay Sharma ◽  
Sabiha Gati ◽  
Maria Bäck ◽  
Mats Börjesson ◽  
...  

2020 ◽  
pp. 194173812097474 ◽  
Author(s):  
Neha P. Raukar ◽  
Leslie T. Cooper

Context: Myocarditis is a known cause of death in athletes. As we consider clearance of athletes to participate in sports during the COVID-19 pandemic, we offer a brief review of the myocardial effects of SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) through the lens of what is known about myocarditis and exercise. All athletes should be queried about any recent illness suspicious for COVID-19 prior to sports participation. Evidence Acquisition: The PubMed database was evaluated through 2020, with the following keywords: myocarditis, COVID-19, SARS-CoV-2, cardiac, and athletes. Selected articles identified through the primary search, along with position statements from around the world, and the relevant references from those articles, were reviewed for pertinent clinical information regarding the identification, evaluation, risk stratification, and management of myocarditis in patients, including athletes, with and without SARS-CoV-2. Study Design: Systematic review. Level of Evidence: Level 3. Results: Since myocarditis can present with a variety of symptoms, and can be asymptomatic, the sports medicine physician needs to have a heightened awareness of athletes who may have had COVID-19 and be at risk for myocarditis and should have a low threshold to obtain further cardiovascular testing. Symptomatic athletes with SARS-CoV-2 may require cardiac evaluation including an electrocardiogram and possibly an echocardiogram. Athletes with cardiomyopathy may benefit from cardiac magnetic resonance imaging in the recovery phase and, rarely, endocardial biopsy. Conclusion: Myocarditis is a known cause of sudden cardiac death in athletes. The currently reported rates of cardiac involvement of COVID-19 makes myocarditis a risk, and physicians who clear athletes for participation in sport as well as sideline personnel should be versed with the diagnosis, management, and clearance of athletes with suspected myocarditis. Given the potentially increased risk of arrhythmias, sideline personnel should practice their emergency action plans and be comfortable using an automated external defibrillator.


2020 ◽  
Vol 41 (43) ◽  
pp. 4191-4199 ◽  
Author(s):  
Werner Budts ◽  
Guido E Pieles ◽  
Jolien W Roos-Hesselink ◽  
Maria Sanz de la Garza ◽  
Flavio D’Ascenzi ◽  
...  

Abstract Improved clinical care has led to an increase in the number of adults with congenital heart disease (CHD) engaging in leisure time and competitive sports activities. Although the benefits of exercise in patients with CHD are well established, there is a low but appreciable risk of exercise-related complications. Published exercise recommendations for individuals with CHD are predominantly centred on anatomic lesions, hampering an individualized approach to exercise advice in this heterogeneous population. This document presents an update of the recommendations for competitive sports participation in athletes with cardiovascular disease published by the Sports Cardiology & Exercise section of the European Association of Preventive Cardiology (EAPC) in 2005. It introduces an approach which is based on the assessment of haemodynamic, electrophysiological and functional parameters, rather than anatomic lesions. The recommendations provide a comprehensive assessment algorithm which allows for patient-specific assessment and risk stratification of athletes with CHD who wish to participate in competitive sports.


Sign in / Sign up

Export Citation Format

Share Document